Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 111

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 111
---
 are summarized below ($ in millions):

| Revenue:                   |     |      |    |     | 2025 |    |     | 2026 |    |     | 2027 |    |     | 2028 |    |     | 2029 |    |     | 2030 |    |     | 2031 |    |
|:---------------------------|:----|-----:|---:|:----|-----:|---:|:----|-----:|---:|:----|-----:|---:|:----|-----:|---:|:----|-----:|---:|:----|-----:|---:|:----|-----:|---:|
| FYARRO (PEComa—US)         |     |      |    |     |    $ | 28 |     |    $ | 31 |     |    $ | 32 |     |    $ | 33 |     |    $ | 34 |     |    $ | 35 |     |    $ | 36 |
| FYARRO (PEComa—EU royalty) |     |      |    |     |      |  — |     |      |  — |     |    $ |  1 |     |    $ |  2 |     |    $ |  3 |     |    $ |  3 |     |    $ |  4 |
| Total Revenue              |     |      |    |     |    $ | 28 |     |    $ | 31 |     |    $ | 32 |     |    $ | 34 |     |    $ | 37 |     |    $ | 38 |     |    $ | 39 |
| EBIT (1)                   |     |      |    |     |    $ |  7 |     |    $ | 11 |     |    $ | 13 |     |    $ | 14 |     |    $ | 16 |     |    $ | 17 |     |    $ | 17 |
|                            |     | 2032 |    |     | 2033 |    |     | 2034 |    |     | 2035 |    |     | 2036 |    |     | 2037 |    |     | 2038 |    |     | 2039 |    |
| Revenue: